Article

Cost–effectiveness of treatments for high-risk myelodysplastic syndromes after failure of firstline hypomethylating agent therapy

Expert Review of Pharmacoeconomics & Outcomes Research
Cancer, Cost Effectiveness Analysis, Economic Models, Hematology, Myelodysplastic Syndrome, Oncology
Article

Cost-Effectiveness of Cetuximab as First-line Treatment for Metastatic Colorectal Cancer in the United States

American Journal of Clinical Oncology
Cancer, Colorectal Cancer, Cost Effectiveness Analysis, Economic Models, Oncology
Poster

Cost Effectiveness of Metal Stents in Pancreatic Cancer

ASCO Gastrointestinal Cancers Symposium
Cancer, Cost Effectiveness Analysis, Economic Models, Oncology, Pancreatic Cancer
Poster

Cost-effectiveness of Cetuximab as first-line treatment for metastatic colorectal cancer in the US

ISPOR Annual International Meeting
Cancer, Colorectal Cancer, Cost Effectiveness Analysis, Economic Models, Oncology
Article

Cost–effectiveness of bronchial thermoplasty in commercially-insured patients with poorly controlled, severe, persistent asthma

Expert Review of Pharmacoeconomics and Outcomes Research
Poster

Cost Effectiveness of Treatments After Failure of a First-Line Hypomethylating Agent in Myelodysplastic Syndromes (MDS)

American Society of Hematology 56th Annual Meeting
Cancer, Cost Effectiveness Analysis, Economic Models, Hematology, Myelodysplastic Syndrome
Article

Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States

Journal of Medical Economics
Cost Effectiveness Analysis, Economic Models, Psychiatry, Schizophrenia
Poster

Cost-Effectiveness of Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir Compared with Efavirenz/Emtricitabine/Tenofovir as First-Line HIV Antiretroviral Therapy in the US Adult Population

ISPOR Annual International Meeting